| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing amylase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amylase (substance) |
Inferred relationship |
Some |
1 |
| amylase + lipase + protease 16600 enheder/5000 enheder/18750 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 20000 enheder/4500 enheder/25000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase 20000 enheder + lipase 5000 enheder + protease 20000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 25000 enheder/4000 enheder/25000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 30000 enheder/10000 enheder/30000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 30000 enheder/8000 enheder/30000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 30000 enheder/8000 enheder/30000 enheder tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 3000 enheder/2400 enheder/3000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 33200 enheder/10000 enheder/37500 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 39000 enheder/12000 enheder/39000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 40000 enheder/8000 enheder/45000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 48000 enheder/16000 enheder/48000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 56000 enheder/20000 enheder/44000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| Amylase + lipase + protease 58500unt/18000unt/58500unt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 58500 enheder/18000 enheder/58500 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 6000 enheder/16000 enheder/6000 enheder tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 65000 enheder/20000 enheder/65000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 66400 enheder/20000 enheder/75000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 664400 enheder/20000 enheder/75000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease pulver a 70000 enheder/16800 enheder/70000 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 8000 enheder/30000 enheder/30000 enheder tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + pancreaslipase + pancreasprotease, tablet à 12500 enheder/1000 enheder/12500 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + pancreaslipase + pancreasprotease, kapsel à 65000 enheder/20000 enheder/65000 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease 12000 enheder/4000 enheder/12000 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| amylase + lipase + protease |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
1 |
| Product containing amylase and pancrelipase and triacylglycerol lipase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amylase (substance) |
Inferred relationship |
Some |
1 |
| Amylase clearance (procedure) |
Component |
True |
Amylase (substance) |
Inferred relationship |
Some |
1 |
| pancrelipase, amylase:lipase 94,3 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| pancrelipase, amylase:lipase 210,33 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| pancrelipase, amylase:lipase 346,86 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| pancrelipase, amylase:lipase 312,17 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| pancrelipase, amylase:lipase 184,84 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| pancrelipase, amylase:lipase 4500 enheder kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| pancrelipase, amylase:lipase 183,49 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| pancrelipase, amylase:lipase 278,72 %mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| pancrelipase, amylase:lipase 62,81 % |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| pancrelipase, amylase:lipase 62,81 % kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
|
| Fluid sample amylase measurement (procedure) |
Component |
False |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| 24 hour urine amylase output measurement |
Component |
False |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Ascitic fluid amylase measurement (procedure) |
Component |
False |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Beta-amylase (substance) |
Is a |
True |
Amylase (substance) |
Inferred relationship |
Some |
|
| Alpha-amylase (substance) |
Is a |
True |
Amylase (substance) |
Inferred relationship |
Some |
|
| Amylase isoenzyme |
Is a |
True |
Amylase (substance) |
Inferred relationship |
Some |
|
| Isoamylase |
Is a |
True |
Amylase (substance) |
Inferred relationship |
Some |
|
| Plasma amylase level (procedure) |
Component |
False |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase measurement |
Component |
True |
Amylase (substance) |
Inferred relationship |
Some |
1 |
| Amylase/creatinine clearance ratio measurement |
Component |
True |
Amylase (substance) |
Inferred relationship |
Some |
1 |
| Amylase measurement, serum |
Component |
False |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase measurement, pleural fluid |
Component |
False |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase measurement, urine |
Component |
False |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase measurement, peritoneal fluid |
Component |
False |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Measurement of fractional excretion of amylase using urine specimen and serum or plasma specimen (procedure) |
Component |
False |
Amylase (substance) |
Inferred relationship |
Some |
3 |
| Product containing only amylase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amylase (substance) |
Inferred relationship |
Some |
1 |
| Product containing only amylase and substance with protease mechanism of action and triacylglycerol lipase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amylase (substance) |
Inferred relationship |
Some |
1 |
| Amylase and pancrelipase and triacylglycerol lipase only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amylase (substance) |
Inferred relationship |
Some |
1 |
| Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase and endopeptidase and triacylglycerol lipase only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing only amylase and endopeptidase and triacylglycerol lipase in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing amylase and endopeptidase and triacylglycerol lipase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing amylase and endopeptidase and pancreatic lipase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amylase (substance) |
Inferred relationship |
Some |
3 |
| Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amylase (substance) |
Inferred relationship |
Some |
3 |
| Product containing amylase and endopeptidase and triacylglycerol lipase in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase and endopeptidase and pancreatic lipase only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amylase (substance) |
Inferred relationship |
Some |
3 |
| Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
3 |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
3 |
| Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
| Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Amylase (substance) |
Inferred relationship |
Some |
2 |
FHIR